Cardiovascular Systems (CSII) Given Daily News Impact Rating of 0.09

Media coverage about Cardiovascular Systems (NASDAQ:CSII) has been trending somewhat positive on Friday, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardiovascular Systems earned a news sentiment score of 0.09 on Accern’s scale. Accern also gave news headlines about the medical device company an impact score of 46.1790134190041 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Several brokerages have issued reports on CSII. BidaskClub cut shares of Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a research note on Wednesday. Raymond James Financial began coverage on shares of Cardiovascular Systems in a research note on Friday, September 22nd. They set a “market perform” rating on the stock. Needham & Company LLC cut shares of Cardiovascular Systems from a “buy” rating to a “hold” rating and lowered their target price for the stock from $33.11 to $23.00 in a research note on Friday, December 15th. Zacks Investment Research cut shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, October 10th. Finally, William Blair reaffirmed a “market perform” rating on shares of Cardiovascular Systems in a research note on Thursday, December 21st. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $31.50.

Shares of Cardiovascular Systems (CSII) opened at $23.89 on Friday. Cardiovascular Systems has a one year low of $23.00 and a one year high of $33.11. The company has a current ratio of 4.30, a quick ratio of 3.83 and a debt-to-equity ratio of 0.18. The stock has a market cap of $790.41, a price-to-earnings ratio of -398.17 and a beta of 2.52.

Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings results on Wednesday, October 25th. The medical device company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.02. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. The business had revenue of $49.70 million for the quarter, compared to analyst estimates of $51.00 million. During the same quarter in the previous year, the firm earned ($0.06) EPS. The company’s quarterly revenue was down .2% compared to the same quarter last year. sell-side analysts forecast that Cardiovascular Systems will post -0.03 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This story was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.com-unik.info/2018/01/12/cardiovascular-systems-csii-given-daily-news-impact-rating-of-0-09.html.

About Cardiovascular Systems

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Insider Buying and Selling by Quarter for Cardiovascular Systems (NASDAQ:CSII)

What are top analysts saying about Cardiovascular Systems? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cardiovascular Systems and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit